NCT06480773View on ClinicalTrials.gov

Kaposi Sarcoma Chemotherapy and Research (KS-CARE)

Active, not recruitingOBSERVATIONAL
Enrollment

127

Participants

Timeline

Start Date

April 25, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Kaposi SarcomaHIV
Interventions
DRUG

standard of care chemotherapy

intravenous Paclitaxel or the combination of Bleomycin and Vincristine.

Trial Locations (2)

8000

Stellenbosch University and Tygerberg Hospital, Cape Town

Unknown

UNC Project, Kamuzu Central Hospital, Lilongwe

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

UNC Lineberger Comprehensive Cancer Center

OTHER